Thyrocare Technologies Ltd. Earnings/Conference Calls

Thyrocare Technologies Ltd. earnings concalls and investor presentations

Load latest

Thyrocare Technologies Ltd.

11 Jan 2021

894.60

1.88%

Earnings Call

Thyrocare Technologies Ltd - Business Update

BSE India

Intimation about (1) significant business revival in Q3 of the current financial year, after business activities resumed across all states, and the growth in the non-covid business and (2) increase in volume of RT-PCR tests making us most cost effective service provider to the patients.

pdf

Thyrocare Technologies Ltd.

06 Nov 2020

894.60

1.88%

Earnings Call

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith the transcript of the Earnings Call held on Tuesday, November 03, 2020 at 12.00 Noon local time, post declaration of the Company's unaudited financial results (Stand-alone and Consolidated) for Quarter / Half Year ended September 30, 2020. This transcript is also made available at our website. Dr. A. Velumani, Chairman & Managing Director, Mr. Arindam Haldar, CEO, Mr. A. Sundararaju, CFO & Executive Director, Mr. Sachin Salvi, Vice-President- Finance, represented the Company.

pdf

Thyrocare Technologies Ltd.

03 Nov 2020

894.60

1.88%

Earnings Call for Q2FY21 of Thyrocare Technologies

Conference Call with Thyrocare Technologies Management and Analysts on Q2FY21 Performance and Outlook. Listen to the full earnings transcript.

Thyrocare Technologies Ltd.

28 Oct 2020

894.60

1.88%

Investor Presentation

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

We are forwarding a copy of Presentation on Quarterly Results of our company for the quarter / half year ended 30-09-2020. Please note that this is only uploaded in our website, and has not been distributed or advertised in newspapers or otherwise publicised.

pdf

Thyrocare Technologies Ltd.

31 Jul 2020, 08:44PM

894.60

1.88%

Investor Presentation

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

We are forwarding copy of Presentation on Quarterly Results of our company for the quarter ended 30-06-2020. Please note that this is only uploaded in our website, and has not been distributed or advertised in newspapers or otherwise publicised.

pdf

Thyrocare Technologies Ltd.

25 May 2020

894.60

1.88%

Investor Presentation

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

We are forwarding copy of Presentation on Audited Financial Results of our company for the quarter / whole year ended 31-03-2020. Please note that this is only uploaded in our website, and has not been distributed or advertised in newspapers or otherwise publicised.

pdf

Thyrocare Technologies Ltd.

03 Feb 2020

894.60

1.88%

Investor Presentation

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

We are forwarding copy of Presentation on Quarterly Results of our company for the quarter / nine months ended 31-12-2019. Please note that this is only uploaded in our website, and has not been distributed or advertised in newspapers or otherwise publicized.

pdf

Thyrocare Technologies Ltd.

07 Nov 2019

894.60

1.88%

Investor Presentation

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

We are forwarding copy of Presentation on Quarterly Results of our company for the quarter / half year ended 30-09-2019. Please note that this is only uploaded in our website, and has not been distributed or advertised in newspapers or otherwise publicised.

pdf

Thyrocare Technologies Ltd.

12 Aug 2019

894.60

1.88%

Investor Presentation

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

We are forwarding copy of Presentation on Quarterly Results of our company for the quarter ended 30-06-2019. Please note that this is only uploaded in our website, and has not been distributed or advertised in newspapers or otherwise publicised.

pdf

Thyrocare Technologies Ltd.

29 Jun 2019

894.60

1.88%

Earnings Call

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith a transcript of the conference call held on Tuesday, May 21, 2019 at 04.00 P.M. local time, to discuss the Company's Audited financial results (Stand-alone and Consolidated) for the year ended March 31, 2019. Dr. Velumani A., Ph.D., CEO, Mr. A. Sundararaju, CFO, Mr. Sachin Salvi, Vice-President- Finance and Dr. Caesar Sengupta, Vice-President- Operations, represented the Company.

pdf